Clinical Trials Browser

Phase 2 × Not yet recruiting × Hyperthermic Intraperitoneal Chemotherapy × Clear all

NCT07304258 2025-12-26

A Prospective, Phase II Clinical Study of HIPEC Combined With NIPS and Tislelizumab Conversion Therapy for Gastric Cancer With Peritoneal Metastasis With Positive Cytology Alone or PCI Score ≤10

Phase 2 Not yet recruiting

Gastrointestinal

Gastric Cancer Peritoneal Metastases

NCT06544460 2024-08-09

Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance Patients

Phase 2 Not yet recruiting

Ovarian Neoplasms

NCT05095467 2021-10-27

HIPEC-AS in Patients With Peritoneal Metastasis of the Stomach or Esophagogastric Junction

Phase 2 Not yet recruiting

Gastrointestinal

Stomach Neoplasms